Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12928416 | 0.96 | — | — | |
| SCHEMBL14629086 | 0.96 | — | — | |
| SCHEMBL1709035 | 0.96 | — | — | |
| SCHEMBL14389380 | 0.96 | — | — | |
| SCHEMBL16499756 | 0.88 | — | — | |
| SCHEMBL12643691 | 0.83 | FUCA1 (0.35) | FUCA1 | |
| SCHEMBL12643690 | 0.83 | FUCA1 (0.35) | FUCA1 | |
| SCHEMBL22789612 | 0.81 | FUCA1 (0.35) | FUCA1CA1CA2CA4 | |
| SCHEMBL18874786 | 0.81 | FUCA1 (0.35) | FUCA1CA1CA2CA4 | |
| SCHEMBL8541905 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720835-B1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2022-07-13 | — | — | EP | disclosed |
| US-11078146-B2 | Method for preparing ethers of cycloaliphatic or araliphatic diols | BASF SE (DE) | 2021-08-03 | — | — | US | disclosed |
| US-20210171427-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | BASF SE (DE) | 2021-06-10 | — | — | US | disclosed |
| CN-111479795-A | Process for preparing ethers of cycloaliphatic or araliphatic diols | 巴斯夫欧洲公司 | 2020-07-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171427-A1 | METHOD FOR PREPARING ETHERS OF CYCLOALIPHATIC OR ARALIPHATIC DIOLS | DGKI, MGLL, DEGS1 | FUCA1 946/4885CA1 1010/4885CA2 718/4885 |
| US-11078146-B2 | Method for preparing ethers of cycloaliphatic or araliphatic diols | DGKI, MGLL, DEGS1 | FUCA1 946/4885CA1 1010/4885CA2 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.